Compare key investment metrics of 한올바이오파마 and 235980 in real time. Both stocks belong to the 면역항암제 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 한올바이오파마 is larger — ₩2.9T vs 235980's ₩103B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 한올바이오파마's current price of 55,900원 sits at about 64% of its 52-week range (21,100원–75,500원).
- 235980's current price of 3,010원 sits at about 6% of its 52-week range (2,655원–8,650원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 한올바이오파마 | 235980 |
|---|---|---|
| Price | 55,900원 | 3,010원 |
| PBR | 17.49배 | 2.42배 |
| Market Cap | ₩2.9T | ₩103B |
| 52-Week High | 75,500원 | 8,650원 |
| 52-Week Low | 21,100원 | 2,655원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 한올바이오파마 or 235980?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 한올바이오파마 and 235980 PER values.
What is the dividend yield difference between 한올바이오파마 and 235980?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 한올바이오파마 and 235980 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 한올바이오파마 and 235980?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.